Advertisement
Pfizer expects Omicron coronavirus vaccine to be ready in March
- The company says it is already manufacturing doses of shots targeting the variant due to keen interest amid ‘breakthrough’ cases in vaccinated populations
- Moderna, meanwhile, is developing a booster that could address Omicron and other emerging strains in the fall
Reading Time:1 minute
Why you can trust SCMP
5
Pfizer expects a Covid-19 vaccine targeting the Omicron variant to be ready in March, the company’s head said Monday.
Pfizer Chief Executive Officer Albert Bourla told CNBC that Pfizer is already manufacturing doses due to keen interest from governments, as authorities contend with huge Covid-19 infection counts, including large numbers of “breakthrough” Omicron cases in vaccinated populations.
“This vaccine will be ready in March,” Bourla told the network.
“I don’t know if we will need it. I don’t know if and how it will be used.”
Bourla said the existing regime of two vaccine shots and a booster has provided “reasonable” protection against serious health effects from Omicron.
Advertisement